These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 14344120)

  • 1. [ON THE NEUROVIRULENCE TEST OF LIVE POLIOVIRUS VACCINES. I. BASES, TECHNIC AND EVALUATION OF THE RESEARCH ON NEUROVIRULENCE MEASUREMENT IN MONKEYS].
    BONIN O; UNTERHARNSCHEIDT F
    Arch Psychiatr Nervenkr; 1964 Nov; 206():260-71. PubMed ID: 14344120
    [No Abstract]   [Full Text] [Related]  

  • 2. [EVALUATION OF NEURAL LESIONS IN MONKEYS INOCULATED WITH SABIN POLIOVIRUS VACCINE].
    LUSSIER G; PAVILANIS V; DIFRANCO E
    Rev Can Biol; 1964 Sep; 23():323-32. PubMed ID: 14237165
    [No Abstract]   [Full Text] [Related]  

  • 3. PROPERTIES OF A NEW ATTENUATED TYPE 3 POLIOVIRUS. II. NEUROVIRULENCE TESTS ON MONKEYS.
    SIMON J
    Arch Gesamte Virusforsch; 1965; 15():220-33. PubMed ID: 14269256
    [No Abstract]   [Full Text] [Related]  

  • 4. NEUROVIRULENCE FOR MONKEYS OF SABIN'S TYPE 1 POLIOVIRUS PASSED THROUGH HUMAN INTESTINES AS COMPARED WITH ATTENUATED AND VIRULENT POLIOVIRUS STRAINS.
    SIMON J
    J Hyg Epidemiol Microbiol Immunol; 1964; 8():506-15. PubMed ID: 14238949
    [No Abstract]   [Full Text] [Related]  

  • 5. The assessment of OPV vaccines by the monkey neurovirulence test: why and how to qualify the experts in histology of central nervous system.
    Poirier B; Morgeaux S; Fuchs F
    Vaccine; 2002 Nov; 21(1-2):115-9. PubMed ID: 12443669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A STUDY OF SABIN TYPE 1 ORAL VACCINE VIRUS DURING FIVE HUMAN PASSAGES.
    PAVILANIS V; LUSSIER G; FOLEY AR; CHARBONNEAU JH; DIFRANCO E; DUBREUIL R
    Rev Can Biol; 1964 Sep; 23():265-76. PubMed ID: 14237159
    [No Abstract]   [Full Text] [Related]  

  • 7. [ON THE DETERMINATION OF THE NEUROVIRULENCE OF LIVE POLIOVIRUS VACCINES. II. PATHOMORPHOLOGY OF APE POLIOMYELITIS CAUSED BY ATTENUATED POLIOVIRUSES AFTER INTRALUMBAR INJECTION WITH SPECIAL REFERENCE TO DIFFERENCES BETWEEN THE VIRUS TYPES].
    UNTERHARNSCHEIDT F; BONIN O
    Arch Psychiatr Nervenkr; 1965 Mar; 206():454-73. PubMed ID: 14271779
    [No Abstract]   [Full Text] [Related]  

  • 8. INTRATYPIC SERODIFFERENTIATION TESTS ON POLIO TYPE 1 VIRUS STRAINS ISOLATED BEFORE AND AFTER VACCINATION WITH ATTENUATED SABIN TYPE 1 POLIO VACCINE.
    HAHNEMANN F; SIBONI K; GODTFREDSEN A
    Acta Pathol Microbiol Scand; 1964; 61():437-45. PubMed ID: 14164891
    [No Abstract]   [Full Text] [Related]  

  • 9. [THE VALUE OF GENETIC MARKERS OF THE POLIOVIRUS FOR THE EVALUATION OF SUPPOSED INCIDENTS FOLLOWING ORAL VACCINATION].
    POETSCH F
    Zentralbl Bakteriol Orig; 1963 Dec; 191():112-6. PubMed ID: 14119890
    [No Abstract]   [Full Text] [Related]  

  • 10. Experience in Canada with the new revised monkey neurovirulence test for oral poliovirus vaccine.
    Contreras G; Furesz J; Karpinski K; Grinwich K; Gardell C
    J Biol Stand; 1988 Jul; 16(3):195-205. PubMed ID: 2844825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GENETIC MARKERS OF POLIOVIRUS STRAINS ISOLATED FROM PARALYTIC PATIENTS PRIOR TO AND AFTER SABIN VACCINATION PROGRAMS. I. STUDIES ON TYPE 1 STRAINS.
    FURESZ J; ARMSTRONG RE; YAROSH W; NAGLER FP
    Am J Hyg; 1964 Jul; 80():45-54. PubMed ID: 14192769
    [No Abstract]   [Full Text] [Related]  

  • 12. Some aspects of the monkey neurovirulence test used for the assessment of oral poliovirus vaccines.
    Furesz J; Contreras G
    Dev Biol Stand; 1993; 78():61-70. PubMed ID: 8388832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GENETIC MARKERS OF POLIOVIRUS STRAINS ISOLATED FROM PARALYTIC PATIENTS PRIOR TO AND AFTER SABIN VACCINATION PROGRAMS. II. STUDIES ON TYPE 3 STRAINS.
    FURESZ J; ARMSTRONG RE; MOREAU P; NAGLER FP
    Am J Hyg; 1964 Jul; 80():55-61. PubMed ID: 14192770
    [No Abstract]   [Full Text] [Related]  

  • 14. The attenuation of poliovirus neurovirulence.
    Almond JW
    Annu Rev Microbiol; 1987; 41():153-80. PubMed ID: 2825586
    [No Abstract]   [Full Text] [Related]  

  • 15. Preliminary studies on the neurovirulence of poliomyelitis vaccine (oral) prepared in vero cells.
    Guo R; Chen SF; Luo GX; Luo QS; Xu QF
    Proc Chin Acad Med Sci Peking Union Med Coll; 1988; 3(2):104-7. PubMed ID: 2848237
    [No Abstract]   [Full Text] [Related]  

  • 16. Transgenic mice carrying the human poliovirus receptor: new animal models for study of poliovirus neurovirulence.
    Horie H; Koike S; Kurata T; Sato-Yoshida Y; Ise I; Ota Y; Abe S; Hioki K; Kato H; Taya C
    J Virol; 1994 Feb; 68(2):681-8. PubMed ID: 8289371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [On the neurovirulence test of poliomyelitis-live vaccine. V. A statistical method for the evaluation of the experiment for the comparison of neurovirulence in the monkey].
    Seinsche D; Bonin O; Unterharnscheidt F; Schmidt K; Schmidt I
    Arch Psychiatr Nervenkr (1970); 1966; 208(5):433-46. PubMed ID: 4291066
    [No Abstract]   [Full Text] [Related]  

  • 18. Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice.
    Abe S; Ota Y; Koike S; Kurata T; Horie H; Nomura T; Hashizume S; Nomoto A
    Virology; 1995 Feb; 206(2):1075-83. PubMed ID: 7856082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [VIROLOGICAL STUDIES ON 2 PATIENTS WITH PARESIS IN CHRONOLOGICAL RELATION TO VACCINATION WITH ORAL POLIOVACCINE IN APRIL-MAY 1963].
    HAHNEMANN F; SIBONI K; GODTFREDSEN A; VON MAGNUS
    Fra Sundhedsstyr; 1963 Oct; 125():72-3. PubMed ID: 14095905
    [No Abstract]   [Full Text] [Related]  

  • 20. Properties of a new type 3 attenuated poliovirus. V. Neurovirulence tests in monkeys after a passage through the human alimentary tract.
    Simon J; Vonka V; Janda Z
    Arch Gesamte Virusforsch; 1965; 15(5):681-9. PubMed ID: 4285635
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.